Cabometyx is now approved for advanced pancreatic and extra-pancreatic NETs, offering a new treatment option for these patients. The phase 3 CABINET trial showed Cabometyx significantly improved ...
PNETs are classified as functional or non-functional, influencing symptoms and treatment strategies. Tumor grade impacts prognosis and treatment plans. Diagnosis involves imaging, blood tests, and ...
Patients with ‘invisible’ cancer ‘waiting years for diagnosis’ - There is an urgent need to speed up the diagnosis of neuroendocrine cancer.
In this concluding segment, Dr Shaheen focuses on how shared decision making and quality of life considerations guide treatment selection in later line pancreatic neuroendocrine tumor care. She ...
Neuroendocrine cancer is one of the rarest types, which begins with special hormone-making cells scattered through the body, and it was the tumor with which Irrfan Khan was diagnosed back in 2018.
At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on cancer care. A handful of people form the core of your care team, based on the types of treatment you need. You ...
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut ...
Bucks Free Press on MSN
Buckinghamshire woman diagnosed with 'invisible' cancer report finds
A Chesham woman has spoken about her experiences battling a rare form of cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results